Maplight Therapeutics Inc (MPLT)
EBITDA Growth
-113.40%
Quarterly · Period ending:
MPLT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-113.40%period ending
Latest reported-113.40%period ending
MPLT Quarterly EBITDA YoY % (-58.51% → -113.40%)
Year-over-year change
High-resolution chart · PNG
MPLT ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -113.3995% | |
| -172.8814% | |
| -277.5042% | |
| -55.5154% | |
| -62.9999% | |
| -18.0168% | |
| -58.5084% |